Threshold Pharmaceuticals

Threshold is a biotechnology company focused on discovering and developing drugs targeting tumor hypoxia, the low-oxygen condition present in the microenvironment of most solid tumors. This approach offers broad potential for treating a wide range of solid tumors. By selectively targeting tumor cells, they are building a pipeline of drugs that could be more effective than traditional cancer treatments with less toxicity to healthy tissues.